GB2250286A - Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines - Google Patents

Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines Download PDF

Info

Publication number
GB2250286A
GB2250286A GB9111896A GB9111896A GB2250286A GB 2250286 A GB2250286 A GB 2250286A GB 9111896 A GB9111896 A GB 9111896A GB 9111896 A GB9111896 A GB 9111896A GB 2250286 A GB2250286 A GB 2250286A
Authority
GB
United Kingdom
Prior art keywords
compound
formula
product
viii
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9111896A
Other versions
GB9111896D0 (en
Inventor
Brian Leslie Pilkington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of GB9111896D0 publication Critical patent/GB9111896D0/en
Publication of GB2250286A publication Critical patent/GB2250286A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic System
    • C07F1/02Lithium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/06Zinc compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Description

2250236 CHEMICAL PROCESS This invention relates to a process for the
preparation of 2-phenyl-6- (pyrimidin-2-yl)pyridine derivatives, to intermediate compounds used therein and to processes for preparing the intermediate compounds.
According to the present invention there is provided a process for the preparation of a compound of formula (V), wherein V, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy, the process comprising treating a compound of formula (IV), wherein Wt Y and Z are as defined above, with zinc (II) chloride.
In one aspect the present invention provides a process for the preparation of a compound of formula (V), wherein V, Y and Z are as defined above, the process comprising the steps of: a) lithiating a compound of formula (VIII), where W, Y and Z are as defined above and X is bromine or iodine; and, b) treating the product formed in (a) with zinc (II) chloride.
In another aspect the present invention provides a process for the preparation of a compound having the general formula (1), wherein W; Y and Z are as defined above, R 1, R 2 and R 3 are independently hydrogen, alkyl, haloalkyl or alkoxy and R 4, R 5 and R6 are independently hydrogen, chlorine, fluorine, alkyl, haloalkyl or alkoxy, or R 4 and R 5 together form a polymethylene group of the formula -(CH 2)m- in which m is 3 or 4; the process comprising the steps of: a) lithiating a compound of formula (VIII), wherein X, V, Y and Z are as defined above; b) treating the product so formed in (a) with zinc (II) chloride; and c) reacting the product so formed in (b) with a compound of formula (III), in the presence of a suitable catalyst.
The invention includes the steps (b) and (c) individually or in combination.
The process is particularly useful for the preparation of compounds having the general formula (I) wherein W, Y, Z, R 1, R 2, R 3, R 5 and R 6 are all hydrogen and R 4 is methyl.
A suitable compound of formula (VIII) is 2-chlorobromobenzene.
Alkyl and the alkyl moieties of alkoxy and haloalkyl groups contain from 1 to 6, preferably 1 to 4, carbon atoms and are either straight or branched chain groups, for example, methyl, ethyl, n-propyl, iso-propyl, nbutyl, iso-butyl, sec-butyl or tert-butyl- Compounds having the general formula (I) are disclosed in (EP-A-259139) and are useful as fungicides.
The process of the invention is shown in Scheme A. Throughout Scheme A the variables W, Y, Z, X, R I, R 2, R 3, R 4, R 5 and R6 are as defined above.
In step (a) a compound of formula (VIII) is lithiated preferably with an alkyl lithium (for example n-butyl lithium) in a suitable solvent (such as tetrahydrofuran) at a suitable temperature (such as -70 to -1000C, preferably -70 to -78C) to give a product (IV). It is believed that product (IV) has the general formula (IV).
In step (b) the product formed in step (a) (product (IV)) is reacted with zinc (II) chloride in a suitable solvent (for example diethylether) at a suitable temperature (such as in the range -60 to -80C, preferably in the range -70 to -78C) to give a product (V). It is believed that product (V) has the general formula (V).
In step (c) product (V) is reacted with a compound of general formula (III) in the presence of a suitable catalyst (for example tetrakis(triphenylphosphine) palladium.0) in a suitable solvent (for example tetrahydrofuran) and at a suitable temperature.
Compounds of general formula (III), in which R 1, R 2, R 3, R 4, R 5 and R 6 are as defined above, can be prepared by coupling together a dibromopyridine of general formula (VI), wherein R I, R 2 and R 3 are as defined above, with a bromopyrimidine of general formula (VII), wherein R 4 R 5 and R 6 are as defined above. The coupling reaction can be carried out by treating the dibromopyridine (VI) with normal butyl lithium in tetrahydrofuran followed by zinc (II) chloride in diethylether, and then adding tetrakis(triphenylphosphine)palladium with the bromopyrimidine (VII). The reaction is carried out at temperatures of between -70 and 20C.
In a further aspect the present invention comprises the product of the process comprising the steps of: a) lithiating a compound of formula (VIII), wherein X, V, Y and Z are as defined above; and, b) taking the product so formed and reacting it with zinc (II) chloride.
In another aspect the present invention comprises the product of the process of treating a compound of formula (IV), wherein W, Y and Z are as defined above, with zinc (II) chloride.
In a still further aspect the present invention comprises a compound having the general formula (V).
j The following Example illustrates the present invention. Where shown, NMR data are selective; no attempt is made to list every absorption. The following abbreviations are used throughout:
THF = tetrahydrofuran dd = doublet of doublets d = doublet t = triplet S = singlet EXAMPLE 1 This Example illustrates the preparation of 4-methyl-2-(6-(2- chlorophenyl)pyrid-2-yl)pyrimidine, as shown in Scheme B. Reactants 2- chlorobromobenzene (Aldrich) 0.57g (2.98mM) n-butyl lithium 2.5M in hexanes (Aldrich) 1.7ml (4.27mM) zinc (II) chloride LOM in ether (Aldrich) 10ml (lOmM) 4-methyl-2-(6-bromopyrid-2-yl)pyrimidine 0.5g (2mM) tetrakis(triphenylphosphine)palladium 0.05g (catalyst). Method 2-Chlorobromobenzene (dried over molecular sieve 4A) was dissolved in tetrahydrofuran (10ml - freshly distilled from sodium and benzophenone) in dry apparatus under an atmosphere of nitrogen. The resulting solution was then cooled, with stirring, (using a solid CO 2 /acetone bath) to - 78C and a solution of n-butyl lithium was added over 15 minutes at a temperature below 70'C. The colourless solution was then stirred at -78C for 15 minutes before adding the anhydrous zinc (II) chloride solution at below -70C over a period of 20 minutes. The resultant white suspension was stirred at -780C for 30 minutes before adding a solution of 4-methyl2-(6bromopyrid-2-yl) pyrimidine and tetrakis(triphenylphosphine)palladiumO in THF (10ml freshly distilled from sodium/benzophenone). The reaction mixture was then allowed to warm up to room temperature to give a pale yellow solution, from which a white solid began to precipitate. The mixture was then heated to reflux for 30 minutes before cooling and quenching by the addition of a 10% aqueous solution of ethylene diamine tetra acetic acid sodium salt (150ml at pH8). The two layers were seperated and the aqueous solution was extracted with ethyl acetate (2x5Oml). The organic solutions were combined, dried over magnesium sulphate (anhydrous) and evaporated to give a bright yellow gum - yield 0.9g. The gum was purified by flash vacuum chromatography through a 40mmx4Omm diameter plug of silica gel (Merck 7729) eluting with 1x50C dichloromethane then 4x50m1 portions of methyl-t-butyl ether. Fractions 3 to 5 were combined to give a pale yellow gum. Yield 0.397g (70.5%), which solidified on standing. The solid was recrystallised from 10% ethyl acetate in hexane to give lustrous white plates. Mpt. 123.8 - 124.PC. Proton NMR in CDC1 3 at 270 MHz: 7.47(dd); 7.36(m); 7.77(d); 7.92(t); 8. 48(d); 8.79(d); 7.28(d); 2.66(s) ppm. Synthesis of 4-methyl-2-(6bromapyrid-2-yl)pyrimidine 2,6-Dibromopyridine (9.48g, 40mM) was dissolved in tetrahydrofuran (100m1 freshly distilled from sodium/benzophenone) under nitrogen. The solution was then cooled in a solid CO 2 /acetone bath and n-butyl lithium (2.5 molar solution in hexane - 24m1 60mM) was added with stirring over 30 minutes at below -700C. The dark green solution was then stirred at -780C for 1 hour after which time a small sample was removed, quenched by addition of water and extracted with ethyl acetate. Gas chromatography analysis showed only 2-bromopyridine to be present. At this point an anhydrous solution of zinc (II) chloride (1.0 molar in diethylether 120m1 120mM) was added over 30 minutes with the reaction temperature below - 701C. During the addition the colour became a paler green and a green gum precipitated. A solution of tetrakis(triphenylphpsphine)palladium (1.Og catalyst) and 2-bromo-4-methylpyrimidine (9.6g, 39.9mM) in tetrahydrofuran (100C freshly distilled from sodium/benzophenone) was then added over 30 minutes at below -701C. The reaction mixture was allowed to warm up to room temperature before refluxing for 1 hour. After cooling to room temperature the reaction was quenched by pouring into a 10% solution of sodium ethylene diaminetetraacetate in water at pH8 (500m1) and extracting with ethyl acetate (3x500m1). The combined ethyl acetate extracts were washed once with water (100m1), dried over magnesium sulphate and evaporated to give a brown gum (12.1g).
The gum was purified by medium pressure preparative liquid chromatography using silica gel 60 (40-60 micron) and eluting with ethyl acetate to give the product as a pale brown solid. Yield 3.15g (31.5%) The solid was recrystallised from ethyl acetate m.pt 134.5 to 135.10C N.M. R. proton shifts in CDC1 3 at 270 MHz: 7.60(dd); 7.71(t); 8.46(dd); 8. 78(d); 7.19(d); 2.76(s) ppm.
CHEMICAL FORMULAE (in description) cl v 1 -:,, y z R 1 R 2 R 3 4 N NN R R (I) R 6 X cl Z', 1 ";;- W y R R 3 N N Br N R 4 R 5 R 6 (VIII) (III) - 6 CHEMICAL FORMULAE (in description)
Li cl 1 ZJO v ZnCl cl 1 z 'i y R2 R 1 1 N Br B 6 R -/ - N \, N - R1 5 Br (IV) (VI) (Vii) Scheme A X 1 cl ---- li::
y V U, Product (IV) W Product (V) y (Viii) step (a) step (b) R 21 step (c) 1 ', R 3 cl ";" 1 W N N (I) 1 1-t.1 1 1 11 N, - R 5 R 6 z (I) R 4 Scheme B Br 6"Z -- 1 cl n-BuMITHF 1 1011 4 cl1. "- N "-' -- 17-N :' 1 N - Z:-1 1 (1 1.5 Li cl zncl 2 /diethylether -700c CH 3 ZnCl cl 5::P, 1/ :-11 t,'

Claims (8)

1. A process for the preparation of a compound of formula (V):
ZnCl %0 1 cl 1 Z / V Y (V) wherein W, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy, the process comprising treating a compound of formula (IV):
Li 0111, 1 Cl Z Z I W j I Y (IV) wherein W, Y and Z are as defined above, with zinc (II) chloride.
2. A process as claimed in claim 1 for the preparation of a compound of formula (V):
ZnCl ---- 1 cl Z W Y (V) wherein W, Y and Z are as defined in claim 1, the process comprising the steps of:
a) lithiating a compound of formula (VIII):
X 1 "R cl 1 li:
Z j v Y (VIII) wherein W, Y and Z are as defined in claim 1 and X is bromine or iodine; and b) treating the product formed in (a) with zinc (II) chloride.
A process for the preparation of a compound having the general formula (I):
cl v 1 Y R 1 R 2 R
3 N N R
4 N R (I) R 6 wherein W, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy, R', R 2 and R3 are independently hydrogen, alkyl, haloalkyl or alkoxy and R 4, R 5 and R 6 are independently hydrogen, chlorine, fluorine, alkyl, haloalkyl or alkoxy, or R 4 and R5 together form a polymethylene group of the formula -(CH2)m- in which m is 3 or 4; the process comprising the steps of: a) lithiating a compound of formula (VIII):
X cl Z', 1 'I 11 Y (VIII) Z 11 - wherein W, Y and Z are as defined above and X is bromine or iodine; b) treating the product so formed in (a) with zinc (II) chloride; and c) reacting the product so formed in (b) with a compound of formula (III):
R 2 R 1 R 3 1 Br N N R 4 Q;Z 1 N - R 5 R 6 in the presence of a suitable catalyst.
(III) A process as claimed in claim 1, 2 or 3 wherein W, Y and Z are all hydrogen.
5. The product of the process comprising the steps of: a) lithiating a compound of formula (VIII):
X cl Z "" 11 1 V Y (VIII) wherein W, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy; and X is chlorine or bromine; and, b) taking the product so formed and reacting it with zinc (II) chloride.
6. A compound having the general formula (V):
ZnCl cl 1 Z 11 Y (V) wherein V, Y and Z are independently hydrogen, fluorine, chlorine, alkyl or alkoxy.
The product of the process comprising treating a compound of formula (IV):
1 1 cl Z W Li (IV) Y wherein W, Y and Z are as defined in claim 1, with zinc (II) chloride.
8. A proress as claimed in claim 3 substantially as hereinbefore described with reference to Example 1.
GB9111896A 1990-06-11 1991-06-03 Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines Withdrawn GB2250286A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909012974A GB9012974D0 (en) 1990-06-11 1990-06-11 Chemical process

Publications (2)

Publication Number Publication Date
GB9111896D0 GB9111896D0 (en) 1991-07-24
GB2250286A true GB2250286A (en) 1992-06-03

Family

ID=10677407

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909012974A Pending GB9012974D0 (en) 1990-06-11 1990-06-11 Chemical process
GB9111896A Withdrawn GB2250286A (en) 1990-06-11 1991-06-03 Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB909012974A Pending GB9012974D0 (en) 1990-06-11 1990-06-11 Chemical process

Country Status (5)

Country Link
JP (1) JPH04243875A (en)
KR (1) KR920000767A (en)
DE (1) DE4118430A1 (en)
FR (1) FR2663032A1 (en)
GB (2) GB9012974D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019815A1 (en) * 1999-09-13 2001-03-22 Sankio Chemical Co., Ltd. Novel 2-(2-pyridyl)pyrimidine derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636994A1 (en) * 1996-09-12 1998-03-19 Basf Ag Process for the preparation of (2'-fluorophenyl) -3-halopyridines
GB9626635D0 (en) * 1996-12-21 1997-02-12 Zeneca Ltd Zinc reagent and synthesis
KR101008075B1 (en) * 2008-06-27 2011-01-13 주식회사 포스코 method for reducing coil break of hot strip
EP2914587A1 (en) 2012-10-31 2015-09-09 Bayer CropScience AG Novel heterocyclic compounds as pest control agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23565A (en) * 1986-09-05 1989-08-25 Sumitomo Chemical Co Novel pyrimidinylpyrimidine derivatives and a plant disease protectant containing them as the active ingredient

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA 102 (3): 24791j *
CA 113 (25): 23164h *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019815A1 (en) * 1999-09-13 2001-03-22 Sankio Chemical Co., Ltd. Novel 2-(2-pyridyl)pyrimidine derivatives

Also Published As

Publication number Publication date
KR920000767A (en) 1992-01-29
DE4118430A1 (en) 1991-12-12
FR2663032A1 (en) 1991-12-13
GB9111896D0 (en) 1991-07-24
JPH04243875A (en) 1992-08-31
GB9012974D0 (en) 1990-08-01

Similar Documents

Publication Publication Date Title
CA2562216C (en) Process for producing a trifluoro-3-buten-2-one compound
CN102482504B (en) Second nonlinear optic compound and containing its nonlinear optical element
SU999971A3 (en) Process for producing derivatives of pyrimidone-4 or their acid addition salts
CS259894B2 (en) Method of substituted nicotinates preparation
KR20150064747A (en) A process for the preparation of acylphosphanes
US5541329A (en) Intermediates prepared in an asymmetric total synthesis of camptothecin analogs
US7687632B2 (en) Process for the preparation of pyridine derivatives
CN110790763A (en) Process for preparing pyridobipyrimidine and pyridobipyrazole derivatives
CN107501242B (en) D-pi-A type dipyrrole fluorescent dye and synthetic method thereof
Krutosikova et al. Condensed O-, N-heterocycles by the transformation of azidoacrylates
GB2250286A (en) Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines
SA91110352B1 (en) An improved process for the preparation of substituted endolone derivatives
RU2261861C1 (en) Method for preparing 4-amino-2,5-bis-heterocyclylquinazolines
GB2467012A (en) Lanthanide (III) ion complexing compounds, luminescent lanthanide (III) ion complexes and use thereof as fluorescent labels
Sato et al. The synthesis of azoniadithia [6] helicenes
Azadi-Ardakani et al. 2, 2-Disubstituted-1, 2-dihydro-3 H-indol-3-ones by base-and thermal-induced cyclisations of o-azidophenyl s-alkyl ketones and o-azidobenzoyl esters
Björk et al. Improved syntheses of thieno [2, 3‐b]‐and [3, 2‐b]‐fused naphthyridines
Bátori et al. Synthesis and regiospecificity in methylation of pyrido [1, 2‐a] pyrazinium‐1‐and 3‐olates and pyrido [1, 2‐b] pyridazinium‐2‐and 4‐olates
Tanaka et al. Synthesis of 4H‐furo [3, 2‐b] indole derivatives A new heterocyclic ring system
CN110386903B (en) Tetrazine-containing oligomeric phenylene acetylene compound and preparation method thereof
Razus et al. Azulene‐substituted pyranylium salts. Syntheses and products characterization
Lepifre et al. Synthesis of 4H-pyrido [3, 2-b][1, 4] oxazine and 3-substituted-4H-pyrido [3, 2-b][1, 4] oxazines via palladium-catalysed reactions
Croisy-Delcey et al. Aza analogs of lucanthone: synthesis and antitumor and bactericidal properties
Elgemeie et al. Activated nitriles in heterocyclic synthesis: A novel synthetic route to furyl-and thienyl-substituted pyridine derivatives
EP0062068B1 (en) N-phthalidyl-5-fluorouracil derivatives

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)